Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02723604 · ClinicalTrials.gov registry record · NA
Low-Level Laser Therapy for Prevention of Oral Mucositis
A NA study of Mucositis, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT02723604: Completed NA study of Mucositis, sponsored by Barbara Ann Karmanos Cancer Institute.
NCT02723604 is a NA study of Mucositis that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 25 participants, below the 55-participant average among 4 other Mucositis trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02723604, a NA study of Mucositis, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall purpose of this study is to examine the efficacy of prophylactic low-level laser therapy (LLLT) to reduce the incidence of oral mucositis and adverse events in patients receiving combined modality therapy consisting of chemotherapy and radiation therapy for head and neck cancer.
Conditions Studied
Interventions
- DEVICE Low Level Laser Therapy
Study Locations (1)
Michigan
- Wayne State University/Karmanos Cancer Institute - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-03 |
| Est. Completion | 2021-09-13 |
| Phase | NA |
What the finished NCT02723604 record still lists
NCT02723604 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 55-participant average among 4 other Mucositis trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Mucositis appearing as the primary indexed condition, and to 1 intervention - of which Low Level Laser Therapy is the first listed.
NCT02723604 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT02723604 about?
NCT02723604 is a clinical study titled "Low-Level Laser Therapy for Prevention of Oral Mucositis". The overall purpose of this study is to examine the efficacy of prophylactic low-level laser therapy (LLLT) to reduce the incidence of oral mucositis and adverse events in patients receiving combined modality therapy consisting of chemotherapy and radiation therapy for head and neck cancer.
What is the current status of trial NCT02723604?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2016-03. Estimated completion is 2021-09-13.
What conditions does trial NCT02723604 study?
This clinical trial studies the following conditions: Mucositis.
What interventions are being tested in trial NCT02723604?
The interventions under investigation include: Low Level Laser Therapy (DEVICE).
Who is sponsoring clinical trial NCT02723604?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02723604 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mucositis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness
RECRUITING · NA
-
Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment
COMPLETED · NA
-
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
RECRUITING · Phase 2
-
Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia